Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Mural Oncology plc: The Memorandum and Articles of Association were amended pursuant to the Transaction Agreement.
- Change
- charter amendment
Exact text from the filing
Pursuant to the terms of the Transaction Agreement, immediately following the Effective Time, the Memorandum and Articles of Association of the Company were amended in accordance with the resolution approved at the EGM, as set forth on Exhibit 3.1 to this Current Report on Form 8-K and is incorporated herein by reference.
View on SEC.gov
M&A Transactions
SEC 8-K Item 2.01/5.01
confidence 0.9
Mural Oncology plc underwent a change of control involving XOMA Royalty Corporation and XRA 5 Corp. for $2.035 in cash (closed 2025-12-05).
- Action
- change of control
- Counterparty
- XOMA Royalty Corporation and XRA 5 Corp.
- Consideration
- $2.035 in cash
- Closing
- 2025-12-05
Exact text from the filing
the Scheme became effective (the “Effective Time”). At the Effective Time, Sub acquired all of the outstanding ordinary shares, nominal value $0.01 per share, of the Company (the “Ordinary Shares,” and such acquired Ordinary Shares, collectively, the “Mural Shares”) and each holder of Mural Shares outstanding as of 11:59 p.m. Irish local time on December 4, 2025, the business day prior to the occurrence of the Effective Time, obtained the right to receive $2.035 in cash (the “Scheme Consideration”) in exchange for each Mural Share held.
View on SEC.gov